Jason Cassorla
Stock Analyst at Citigroup
(1.89)
# 2,960
Out of 4,728 analysts
40
Total ratings
50%
Success rate
-1.66%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Jason Cassorla
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PACS PACS Group | Reinstates: Buy | $45 | $13.72 | +227.99% | 3 | Sep 11, 2024 | |
| SGRY Surgery Partners | Maintains: Buy | $38 → $36 | $19.85 | +81.36% | 6 | Aug 7, 2024 | |
| THC Tenet Healthcare | Maintains: Buy | $139 → $171 | $127.63 | +33.98% | 7 | Jul 25, 2024 | |
| UHS Universal Health Services | Maintains: Buy | $170 → $193 | $184.16 | +4.80% | 5 | Feb 29, 2024 | |
| HCA HCA Healthcare | Maintains: Buy | $324 → $279 | $305.79 | -8.76% | 5 | Oct 25, 2023 | |
| CLOV Clover Health Investments | Maintains: Neutral | $1 → $1.5 | $3.74 | -59.89% | 3 | Aug 11, 2023 | |
| CYH Community Health Systems | Maintains: Buy | $9 → $7 | $2.91 | +140.55% | 8 | May 3, 2023 | |
| EHAB Enhabit | Maintains: Neutral | $16 → $18 | $7.74 | +132.56% | 2 | Feb 17, 2023 | |
| INNV InnovAge Holding | Maintains: Neutral | $5 → $8 | $3.69 | +116.80% | 1 | Nov 16, 2022 |
PACS Group
Sep 11, 2024
Reinstates: Buy
Price Target: $45
Current: $13.72
Upside: +227.99%
Surgery Partners
Aug 7, 2024
Maintains: Buy
Price Target: $38 → $36
Current: $19.85
Upside: +81.36%
Tenet Healthcare
Jul 25, 2024
Maintains: Buy
Price Target: $139 → $171
Current: $127.63
Upside: +33.98%
Universal Health Services
Feb 29, 2024
Maintains: Buy
Price Target: $170 → $193
Current: $184.16
Upside: +4.80%
HCA Healthcare
Oct 25, 2023
Maintains: Buy
Price Target: $324 → $279
Current: $305.79
Upside: -8.76%
Clover Health Investments
Aug 11, 2023
Maintains: Neutral
Price Target: $1 → $1.5
Current: $3.74
Upside: -59.89%
Community Health Systems
May 3, 2023
Maintains: Buy
Price Target: $9 → $7
Current: $2.91
Upside: +140.55%
Enhabit
Feb 17, 2023
Maintains: Neutral
Price Target: $16 → $18
Current: $7.74
Upside: +132.56%
InnovAge Holding
Nov 16, 2022
Maintains: Neutral
Price Target: $5 → $8
Current: $3.69
Upside: +116.80%